Bloomage Historical Income Statement

688363 Stock

50.12 0.18 0.36%

Historical analysis of Bloomage Biotechnology income statement accounts such as Other Operating Expenses of 6.3 B, Net Income Applicable To Common Shares of 562.4 M or Income Tax Expense of 106.5 M can show how well Bloomage Biotechnology Corp performed in making a profits. Evaluating Bloomage Biotechnology income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bloomage Biotechnology's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Bloomage Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bloomage Biotechnology is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Bloomage Income Statement Analysis

Bloomage Biotechnology Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bloomage Biotechnology shareholders. The income statement also shows Bloomage investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bloomage Biotechnology Income Statement Chart

At present, Bloomage Biotechnology's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 6.3 B, whereas Net Income Applicable To Common Shares is forecasted to decline to about 562.4 M.

Other Operating Expenses Income Tax Expense Tax Provision Selling General Administrative

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bloomage Biotechnology. It is also known as Bloomage Biotechnology overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from Bloomage Biotechnology's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bloomage Biotechnology current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bloomage Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Gross Profit	4.9B	4.5B	5.1B	2.6B
Total Revenue	6.4B	6.1B	7.0B	7.3B

Gross Profit Total Revenue

Bloomage Biotechnology income statement Correlations

	Other Operating Expenses	Income Tax Expense	Minority Interest	Tax Provision	Net Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Interest Income	Ebitda	Reconciled Depreciation
Other Operating Expenses		0.78	0.93	0.73	0.83	0.91	0.91	0.8	0.65	0.62	0.82	0.94	0.94	0.92	0.64	0.63	0.92	0.81	0.96
Income Tax Expense	0.78		0.77	0.93	0.71	0.86	0.87	0.95	0.9	0.87	0.98	0.85	0.85	0.86	0.88	0.87	0.88	0.98	0.81
Minority Interest	0.93	0.77		0.73	0.8	0.96	0.96	0.87	0.72	0.69	0.82	0.97	0.97	0.97	0.7	0.7	0.94	0.84	0.98
Tax Provision	0.73	0.93	0.73		0.69	0.84	0.86	0.9	0.98	0.97	0.9	0.81	0.81	0.83	0.98	0.97	0.86	0.92	0.75
Net Interest Income	0.83	0.71	0.8	0.69		0.84	0.85	0.76	0.69	0.67	0.78	0.86	0.85	0.85	0.68	0.68	0.87	0.77	0.86
Selling General Administrative	0.91	0.86	0.96	0.84	0.84		1.0	0.93	0.85	0.83	0.88	0.99	0.99	1.0	0.83	0.83	0.99	0.92	0.97
Total Revenue	0.91	0.87	0.96	0.86	0.85	1.0		0.93	0.86	0.84	0.89	0.99	0.99	1.0	0.84	0.84	0.99	0.92	0.98
Gross Profit	0.8	0.95	0.87	0.9	0.76	0.93	0.93		0.91	0.89	0.97	0.9	0.9	0.92	0.89	0.89	0.92	0.99	0.87
Operating Income	0.65	0.9	0.72	0.98	0.69	0.85	0.86	0.91		1.0	0.88	0.8	0.8	0.83	1.0	1.0	0.85	0.92	0.74
Net Income From Continuing Ops	0.62	0.87	0.69	0.97	0.67	0.83	0.84	0.89	1.0		0.85	0.77	0.77	0.81	1.0	1.0	0.83	0.89	0.7
Ebit	0.82	0.98	0.82	0.9	0.78	0.88	0.89	0.97	0.88	0.85		0.88	0.87	0.88	0.86	0.85	0.9	0.99	0.85
Research Development	0.94	0.85	0.97	0.81	0.86	0.99	0.99	0.9	0.8	0.77	0.88		1.0	1.0	0.78	0.78	0.99	0.9	0.99
Cost Of Revenue	0.94	0.85	0.97	0.81	0.85	0.99	0.99	0.9	0.8	0.77	0.87	1.0		1.0	0.78	0.77	0.99	0.9	0.99
Total Operating Expenses	0.92	0.86	0.97	0.83	0.85	1.0	1.0	0.92	0.83	0.81	0.88	1.0	1.0		0.81	0.81	0.99	0.91	0.98
Income Before Tax	0.64	0.88	0.7	0.98	0.68	0.83	0.84	0.89	1.0	1.0	0.86	0.78	0.78	0.81		1.0	0.83	0.89	0.71
Net Income	0.63	0.87	0.7	0.97	0.68	0.83	0.84	0.89	1.0	1.0	0.85	0.78	0.77	0.81	1.0		0.83	0.89	0.71
Interest Income	0.92	0.88	0.94	0.86	0.87	0.99	0.99	0.92	0.85	0.83	0.9	0.99	0.99	0.99	0.83	0.83		0.92	0.98
Ebitda	0.81	0.98	0.84	0.92	0.77	0.92	0.92	0.99	0.92	0.89	0.99	0.9	0.9	0.91	0.89	0.89	0.92		0.87
Reconciled Depreciation	0.96	0.81	0.98	0.75	0.86	0.97	0.98	0.87	0.74	0.7	0.85	0.99	0.99	0.98	0.71	0.71	0.98	0.87

Click cells to compare fundamentals

Bloomage Biotechnology Account Relationship Matchups

High Positive Relationship

Total Revenue	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Total Revenue
Net Income From Continuing Ops	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income

High Negative Relationship

Not Found

Bloomage Biotechnology income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Operating Expenses	22.6M	30.5M	53.9M	5.2B	6.0B	6.3B
Net Income Applicable To Common Shares	585.6M	645.8M	782.3M	970.1M	1.1B	562.4M
Income Tax Expense	116.5M	113.9M	114.6M	168.4M	193.7M	106.5M
Minority Interest	(1.6M)	6.8M	9.5M	9.8M	11.3M	11.9M
Tax Provision	113.9M	114.6M	174.7M	119.0M	136.8M	117.2M
Net Interest Income	17.5M	12.5M	23.5M	26.9M	30.9M	32.5M
Selling General Administrative	1.1B	2.5B	3.2B	3.0B	3.4B	3.6B
Total Revenue	2.6B	4.9B	6.4B	6.1B	7.0B	7.3B
Gross Profit	2.1B	3.9B	4.9B	4.5B	5.1B	2.6B
Operating Income	759.8M	914.4M	1.1B	737.7M	848.3M	730.2M
Net Income From Continuing Ops	645.0M	775.6M	961.4M	582.7M	670.2M	613.9M
Ebit	669.0M	670.0M	749.6M	1.1B	1.3B	682.8M
Research Development	141.2M	284.3M	388.2M	446.3M	513.3M	539.0M
Cost Of Revenue	489.5M	1.1B	1.5B	1.6B	1.9B	2.0B
Total Operating Expenses	1.9B	4.0B	5.2B	5.3B	6.1B	6.4B
Income Before Tax	758.9M	890.2M	1.1B	701.7M	807.0M	731.1M
Net Income	645.8M	782.3M	970.9M	592.6M	681.4M	617.8M
Interest Income	18.0M	24.4M	38.5M	38.5M	44.2M	46.4M
Ebitda	763.1M	829.1M	1.1B	1.4B	1.6B	901.4M
Reconciled Depreciation	70.2M	154.3M	213.6M	264.7M	304.4M	319.6M

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Bloomage Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bloomage Historical Income Statement

About Bloomage Income Statement Analysis

Bloomage Biotechnology Income Statement Chart

Other Operating Expenses

Tax Provision

Bloomage Biotechnology income statement Correlations

Bloomage Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bloomage Biotechnology income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Expense	Other Operating Expenses
Net Income Applicable To Common Shares	Income Tax Expense
Minority Interest	Tax Provision
Net Interest Income	Selling General Administrative
Total Revenue	Gross Profit
Operating Income	Net Income From Continuing Ops
Ebit	Research Development
Cost Of Revenue	Total Operating Expenses
Income Before Tax	Net Income
Interest Income	Ebitda
Reconciled Depreciation